Nissan Sentra Recall Issued Over Defective Brake Lights

Luke Tollen

Add Your Comments

As a result of problems with brake lights that may not illuminate properly, more than 800,000 Nissan Sentra sedans are being recalled by the manufacturer.

The National Highway Traffic Safety Administration (NHTSA) announced the Nissan Sentra recall on March 5, warning owners the brake light switch may become contaminated with grease, preventing the circuit from closing and the lights activating. This may increase the risk of an auto accident if other drivers do not recognize a vehicle is slowing or has stopped.

The recall comes after an issue was discovered with a silicone-based grease, which may result in the break light switch becoming contaminated with built-up residue. This would further lead to an open circuit issue and an inoperative stop lamp switch.

Do You Know about…

Spinal Cord Stimulator lawsuits

Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION
Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

Do You Know About…

Spinal Cord Stimulator lawsuits

Spinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.

Learn More
SEE IF YOU QUALIFY FOR COMPENSATION

The NHTSA warns owners may notice a malfunction light on, the rear stop lights may not illuminate and potentially the engine may not start.

The recall affects Nissan Sentra vehicles from model years 2016 through 2019, which were manufactured between December 1, 2015 and November 23, 2019.

NHTSA released a report on March 4 stating that potentially 807,376 Sentra’s are involved in the nationwide recall. Nissan also mentioned that it is not aware of any crashes or injuries related to the problem. This does not affect other Nissan or INFINITI models due to the uniqueness of where the parts are located in the 2016-2019 Nissan Sentra models.

“This issue is unique to Model Year 2016-2019 Nissan Sentra vehicles due to the combination of clevis pin grease that uses a high concentration of silicon, and a bulb system that uses a high current switch,” the NHTSA warns. “Specifically, the layout of the clevis pin and brake lamp switch being in close proximity to one another is unique on the Sentra model.”

Nissan will notify owners of affected vehicles at the beginning of April 2021. Dealers will replace the brake light switch and install a protective grommet at no cost to the owner. Also, remedy parts will be made available in fall of 2021.

Owners may contact Nissan customer service at 1-800-867-7769 or use Nissan’s recalls site.

Tags: Auto Accident, Auto Recall, Nissan, Nissan Sentra Recall

More Lawsuit Stories

2 Comments

Patricia
My car had a problem not starting before and the problem happened again took my car to Nissan Union City and they told me the problem and said they fixed it so it can start. I was headed to work on March 12th and notice my car was going slow but the gage said 65mph. Warning signs came on dash and I pulled over called them and they told me to bring it the next day. I had to get my car jumped off from my drive way because the what ever they did the brake light would not go out over night. now it’s May 20th and they are telling me it will be August. All they are telling me is the parts not in. I am so frustrated at this point.
Deidre
I have a Nissan Sentra within the past two weeks I malfunction notification came up on my dashboard and now my vehicle is not starting up Nissan has notified me, That it is a recall and I have to wait up to 10 to 14 weeks for the problem to be fixed or have to wait beginning fall and I have to put on a list to get this issued fix and there is no guarantees so I have no working vehicle

This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Drug Makers Agree Dupixent Cancer Lawsuits Should Be Centralized in MDL
Regeneron and Sanofi-Aventis agree with calls to consolidate all Dupixent cancer lawsuits currently spread throughout the federal court system before one judge.
MORE ABOUT: DUPIXENT LAWSUIT
Depo-Provera Meningioma Lawyers Reappointed to MDL Leadership Roles
A group of about 70 Depo-Provera meningioma lawyers have been reappointed to key leadership roles in the litigation, as thousands of women seek compensation for brain tumors they say were caused by the birth control shots.